AKB-6899

N/A

Report date: 2025/06/10 17:55:04
NME

Base Information

Drug NameAKB-6899
Drug Alias Namehypoxia inducible factor-prolyl hydroxylase inhibitor (Akebia)AKB-6899
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitorsVascular endothelial growth factor receptor stimulants
TargetsHypoxia-inducible factor prolyl hydroxylaseVascular endothelial growth factor receptor
Therapy Area/IndicationsEye DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAkebia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAkebia Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsEye DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A